Redmile Group, LLC
Q2 2025 13F Holdings
- Locationsan francisco, CA
- Num holdings
48
- Value ($000)
$939,575
- Date Filed08/14/2025
- Form type13F-HR
- CIK0001425738
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
SRRK SCHOLAR ROCK HLDG CORP | COM | 80706P103 | $139.17M | 15 % | 3,929,039 | ||
KRYS KRYSTAL BIOTECH INC | COM | 501147102 | $91.20M | 10 % | 663,471 | ||
ZYME ZYMEWORKS INC | COM | 98985Y108 | $52.09M | 6 % | 4,150,627 | ||
STOK STOKE THERAPEUTICS INC | COM | 86150R107 | $49.67M | 5 % | 4,375,931 | ||
IMNM IMMUNOME INC | COM | 45257U108 | $45.31M | 5 % | 4,872,225 | ||
REPL REPLIMUNE GROUP INC | COM | 76029N106 | $43.34M | 5 % | 4,664,791 | ||
NRIX NURIX THERAPEUTICS INC | COM | 67080M103 | $42.52M | 5 % | 3,732,888 | ||
LIVANOVA PLC | SHS | G5509L101 | $42.06M | 5 % | 934,271 | ||
ADC THERAPEUTICS SA | SHS | H0036K147 | $41.99M | 5 % | 15,666,731 | ||
AKRO AKERO THERAPEUTICS INC | COM | 00973Y108 | $41.32M | 4 % | 774,311 |
Rows Per Page
10
- 10
- 50
- 100